Apart from its use in endocrinology and rheumatology, therapeutic nuclear medicine is
developing rapidly as an additional treatment modality in oncology. Many different specific …

There are currently 6 unconjugated antibodies and 3 immunoconjugates approved for use in
the United States in a variety of cancers, with a considerable number of new agents in …

OBJECTIVE: We report the safety and feasibility of using convection-enhanced delivery to
administer Cotara (Peregrine Pharmaceuticals, Inc., Tustin, CA), a novel …

Purpose The aim of the study was to evaluate the effect of phosphorus-32 colloid ([32 P])
intracavitary irradiation on the treatment of patients with cystic craniopharyngiomas. Methods …

✓ Treatment of high-grade astrocytoma includes surgery, chemotherapy, and various
methods of irradiation. Radiation therapy usually results in necrosis and edema around the …

There are many radionuclides with a wide range of energies and half-lives available for use
as non-sealed radiotherapeutic agents. To date, no single radionuclide has emerged as …

Introduction Cystic glioblastoma is a well-recognised clinical entity but the characteristics
and role of these cystic components in determining clinical outcome remains poorly …

Although cystic gliomas of the brain stem can be readily aspirated using a stereotactic
technique, they will frequently recur, resulting in progressive neurological deficit. Since …

Purpose 32 P-chromic phosphate colloid treatments of astrocytoma and craniopharyngioma
cystic brain tumours in paediatric patients are conventionally based on a sphere model …

There is a lack of standardized methodology to perform dose calculations for targeted
radionuclide therapy and at present no method exists to objectively evaluate the various …